Dana-Farber News shared on X:
“Congratulations to Varadha Balaji on an NCI K99/R00 award for research in Misha Beltran’s lab at Dana-Farber investigating the epigenetic drivers of treatment resistance in neuroendocrine prostate cancer, an aggressive disease with no approved targeted therapies.”
Defining epigenetic underpinnings of neuroendocrine lineage carcinomas
Other articles about prostate cancer on OncoDaily.